Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. The company is headquartered in Beijing, Beijing and currently employs 595 full-time employees. The company went IPO on 2009-12-11. The firm operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The firm mainly conducts its business in the domestic market.
Follow-Up Questions
What is Concord Medical Services Holdings Ltd (CCM)'s P/E Ratio?
The P/E ratio of Concord Medical Services Holdings Ltd is N/A
Who is the CEO of Concord Medical Services Holdings Ltd?
Dr. Jianyu Yang is the Chairman of the Board of Concord Medical Services Holdings Ltd, joining the firm since 2008.
What is the price performance of CCM stock?
The current price of CCM is 5.15, it has increased 0.3% in the last trading day.
What are the primary business themes or industries for Concord Medical Services Holdings Ltd?
Concord Medical Services Holdings Ltd belongs to Health Care industry and the sector is Health Care
What is Concord Medical Services Holdings Ltd market cap?
Concord Medical Services Holdings Ltd's current market cap is $223.8
Is Concord Medical Services Holdings Ltd a buy, sell, or hold?
According to wall street analysts, 0 analysts have made analyst ratings for Concord Medical Services Holdings Ltd, including 0 strong buy, 0 buy, 2 hold, 5 sell, and 0 strong sell
